A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)

NCT05244980 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia, Androgenetic

Interventions

DRUG: TDM-105795
DRUG: Placebo

Sponsor

Technoderma Medicines Inc.

Collaborators

[object Object]